Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested
the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4
Gel administered once daily to 50 cm2 of skin for 14 days.